【24h】

Winning The Battle Against HIV-1

机译:赢得对抗HIV-1的战斗

获取原文
           

摘要

Objective: To present an entirely new theory and practical solution to completely eliminate HIV-1 from the human body, based on a combination between a HAART regimen (HAART-x) and a corresponding, pre-administrated-to-(HAART-x), therapeutic vaccine (Vaccine-x) made of short HIV-1 DNA-sequences containing the point-mutations (resistance-mutations-pattern) that would be induced into HIV-1's genome by the corresponding, following, to come, HAART regimen (HAART-x).Design and methods: HIV-1's ability and need to mutate under HAART pressure is exploited, and the synergetical scissoring effect on HIV-1 of each (Vaccine, HAART)-couple is used to eradicate HIV-1 from the human body. Knowing in advance, the HIV-1 resistance - mutations - pattern for each antiretroviral drug, and also for any HAART or Mega-HAART regimen, (e.g. from Stanford University HIV Drug Resistance Database, http://hivdb.stanford.edu/ ), HIV-1 DNA therapeutic vaccines can be designed, produced and administrated to HIV-1 positive patients, prior to their usual, corresponding HAART regimens, and these HIV-1 DNA therapeutic vaccines prevent and hinder the emergence of drug-resistant HIV-1 (or HAART-resistant HIV-1), and thus contribute together with HAART, to the eradication of HIV-1 from the human body, and cure AIDS.Results:The general HIV-1 eradication scheme is a succession, or series, of (Vaccine-x, HAART-x)-couples:(Vaccine-1, HAART-1 ) ---> (Vaccine-2 , HAART-2) ---> (Vaccine-3 , HAART-3 ) --->........---> (Vaccine-x , HAART-x) --->........---> (Vaccine-n , HAART-n)---> Eradication and indicates that each therapeutic-vaccine (Vaccine-x) is pre-administrated to its corresponding (HAART-x) regimen. Also, each anti HIV-1 therapeutic-vaccine (Vaccine-x) is made of short HIV-1 - DNA - sequences which contain the point-mutations (resistance-mutations-pattern) that would be induced into HIV-1's genome by the corresponding, following, to come, HAART regimen (HAART-x).Conclusions:HIV-1 can be be eliminated from the human body, by treatment with successive (Vaccine-x, HAART-x)-couples, followed by (Vaccine-x , Mega-HAART-x)-couples
机译:目的:基于HAART方案(HAART-x)与相应的预先给药(HAART-x)的结合,提出一种全新的理论和实用的解决方案,以从人体中完全消除HIV-1 ,由短的HIV-1 DNA序列制成的治疗性疫苗(Vaccine-x),其中含有点突变(耐药突变模式),该突变将由相应的HAART方案诱导为HIV-1的基因组(设计和方法:利用HIV-1在HAART压力下变异的能力和需要,并利用协同剪切效应对每个(疫苗,HAART)夫妇的HIV-1进行消灭。人体。预先了解每种抗逆转录病毒药物以及任何HAART或Mega-HAART方案的HIV-1耐药性-突变-模式(例如,来自斯坦福大学HIV耐药性数据库,http://hivdb.stanford.edu/) ,可以在通常的相应HAART方案之前,为HIV-1阳性患者设计,生产和施用HIV-1 DNA治疗疫苗,这些HIV-1 DNA治疗疫苗可以预防和阻碍耐药性HIV-1的出现(或抗HAART的HIV-1),从而与HAART一起从人体中消除HIV-1,并治愈AIDS。结果:一般的HIV-1消除方案是一系列的或一系列的(Vaccine-x,HAART-x)-对:(Vaccine-1,HAART-1)--->(Vaccine-2,HAART-2)--->(Vaccine-3,HAART-3)--- > ........--->(疫苗x,HAART-x)---> ........--->(疫苗n,HAART-n)- >根除,表示每种治疗疫苗(Vaccine-x)均已预先接种至其相应的(HAART-x)r 。而且,每种抗HIV-1治疗疫苗(Vaccine-x)都由短的HIV-1-DNA-序列组成,这些序列包含点突变(抗性突变模式),该突变会被病毒诱导为HIV-1的基因组。结论:结论:先通过连续(Vaccine-x,HAART-x)-偶合,然后再使用(Vaccine- x,Mega-HAART-x)-对

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号